← All trials
NCT05592093
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 20, 2022
- Primary completion
- Jul 1, 2023
- Completion date
- Sep 1, 2023
- First posted
- Oct 24, 2022
- Last posted
- Oct 25, 2022
- Enrollment
- 900
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jiao Tong UniversityLead sponsor
- Capital Medical UniversityCollaborator
- Capital Medical UniversityStudy director
- Jiao Tong UniversityCollaborator
- Jiao Tong UniversityStudy director
- Jiao Tong UniversityReponsible party - principal investigator
- Capital Medical UniversityOfficial
- Jiao Tong UniversityOfficial
- Jiao Tong UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.